A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
Clinical trial NCT05773586 · RECRUITING
Trial details
- NCT number
- NCT05773586
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2027-12-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.